Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-08-15

FDA Approved: NEXOBRID — Supplemental Application (Vericel Corporation)

View source ↗

Summary

The FDA approved a supplemental application for NEXOBRID (ANACAULASE-BCDB) from Vericel Corporation, indicating an update to the product's approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NEXOBRID (ANACAULASE-BCDB)

Snippet

SUPPL AP for NEXOBRID (ANACAULASE-BCDB)